Erythropoietin therapy for premature infants: cost without benefit?
A
A
Zipursky
D001118:Argentina; D001803:Blood Transfusion / Q000191:economics; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D004921:Erythropoietin / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin